No safety issues potentially related to the intervention were identified during the study.<h4>Conclusion</h4>In conclusion, remote insulin dose adjustment based on interstitial glucose monitoring ameliorates glucose control in nursing home residents with T2D on basal-bolus insulin therapy. This evidence concerns the gene INS and type 2 diabetes mellitus.